Recommend Products

Special Offer

Bulk Products

New Arrivals

Hot Sales

Publication Products

Publication Products

Chemical Structure Cat. No. Product Name CAS No.
Lapatinib Chemical Structure
BCP01874 Lapatinib 231277-92-2
Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.
Camptothecin Chemical Structure
BCP02857 Camptothecin 7689-03-4
Camptothecin is a potent DNA enzyme topoisomerase I inhibitor with an IC50 and IC70 of 50 nM and 0.225 μM for breast cancer cell line MDA-MB-231.
LY294002 Chemical Structure
BCP00195 LY294002 154447-36-6
LY294002 is a highly selective inhibitor of phosphatidylinositol 3-kinase.
Rapamycin Chemical Structure
BCP01404 Rapamycin 53123-88-9
Rapamycin is antifungal and immunosuppressant and specific inhibitor of mTOR.
Cabazitaxel Chemical Structure
BCP27641 Cabazitaxel 183133-96-2
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
Plerixafor Chemical Structure
BCP02337 Plerixafor 110078-46-1
Plerixafor (AMD3100) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
Empagliflozin Chemical Structure
BCP06962 Empagliflozin 864070-44-0
Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes.
CL2A-SN-38 Chemical Structure
BCP32728 CL2A-SN-38 1279680-68-0
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).
Cintirorgon Chemical Structure
BCP28882 Cintirorgon 2055536-64-4
Cintirorgon (LYC-55716) is novel oral RAR-related orphan receptor γ (RORγ) agonist.
GDC-0941 Chemical Structure
BCP01714 GDC-0941 957054-30-7
GDC-0941 is a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer.
Vandetanib Chemical Structure
BCP01925 Vandetanib 443913-73-3
Vandetanib is a multi-kinase inhibitor that is used in the therapy of advanced or metastatic medullary thyroid cancer. Vandetanib therapy is commonly associated with transient elevations in serum aminotransferase during therapy, but has not been linked to cases of clinically apparent acute liver injury with jaundice.
ABT-737 Chemical Structure
BCP01725 ABT-737 852808-04-9
ABT-737 is a pan-Bcl-2 inhibitor that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and xenografts.
U0126-EtOH Chemical Structure
BCP05458 U0126-EtOH 1173097-76-1
U0126-EtOH is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 μM/0.06 μM, 100-fold higher affinity for ΔN3-S218E/S222D MEK than PD98059. This inhibition of MEK1/2 is noncompetitive with ERK and ATP.
Afatinib Chemical Structure
BCP04467 Afatinib 850140-72-6
Afatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2.
AZD8055 Chemical Structure
BCP02171 AZD8055 1009298-09-2
AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.
Sofosbuvir Chemical Structure
BCP06035 Sofosbuvir 1190307-88-0
PSI-7977 is an investigational nucleotide analog currently in Phase 2 for treatment of chronic HCV infection.
Daclatasvir Chemical Structure
BCP02431 Daclatasvir 1009119-64-5
Daclatasvir (BMS-790052; EBP 883) is a first-in-class, highly-selective oral HCV NS5A inhibitor.
Asunaprevir Chemical Structure
BCP08230 Asunaprevir 630420-16-5
Asunaprevir is an inhibitor of the viral enzyme serine protease HCV NS3.
Simeprevir Chemical Structure
BCP07504 Simeprevir 923604-59-5
Simeprevir is an oral, direct acting hepatitis C virus (HCV) protease inhibitor that is used in combination with other antiviral agents in the treatment of chronic hepatitis C, genotypes 1 and 4. Simeprevir has been linked to isolated, rare instances of mild, acute liver injury during treatment and to occasional cases of hepatic decompensation in patients with preexisting cirrhosis.
Telaprevir Chemical Structure
BCP01919 Telaprevir 402957-28-2
Telaprevir is an investigational oral hepatitis C virus (HCV) protease inhibitor with an IC50 of < 0.2 μM.
123下一页末页共 103 条记录 1 / 6 页